🇺🇸 Fluorometholone 1% topical ocular steroid in United States

FDA authorised Fluorometholone 1% topical ocular steroid on 12 January 1972

Marketing authorisations

FDA — authorised 12 January 1972

  • Application: NDA016851
  • Marketing authorisation holder: ABBVIE
  • Local brand name: FML
  • Indication: SUSPENSION/DROPS — OPHTHALMIC
  • Status: approved

Read official source →

FDA — authorised 4 September 1985

  • Application: NDA017760
  • Marketing authorisation holder: ALLERGAN
  • Local brand name: FML
  • Indication: OINTMENT — OPHTHALMIC
  • Status: approved

Read official source →

Frequently asked questions

Is Fluorometholone 1% topical ocular steroid approved in United States?

Yes. FDA authorised it on 12 January 1972; FDA authorised it on 4 September 1985.

Who is the marketing authorisation holder for Fluorometholone 1% topical ocular steroid in United States?

ABBVIE holds the US marketing authorisation.